Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$34.8M |
| 2 |
Kinder Morgan
KMI
|
+$27.8M |
| 3 |
EOG Resources
EOG
|
+$27.5M |
| 4 |
Medtronic
MDT
|
+$27.1M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$42.7M |
| 2 |
Apple
AAPL
|
+$36.5M |
| 3 |
Comcast
CMCSA
|
+$33.5M |
| 4 |
CVS Health
CVS
|
+$30.9M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.53% |
| 2 | Technology | 15.96% |
| 3 | Consumer Discretionary | 14.59% |
| 4 | Healthcare | 13.04% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.51T
| $51.1M | 1.42% |
803,420
-496,692
| -38% | -$36.5M |
|
2
Biogen
BIIB
$32B
| $42.4M | 1.18% |
133,975
-25,791
| -16% | -$7.83M |
|
3
Chevron
CVX
$403B
| $42.4M | 1.18% |
584,902
+160,626
| +38% | +$15.9M |
|
4
Microsoft
MSFT
$3.59T
| $33.7M | 0.94% |
213,593
-86,688
| -29% | -$14.3M |
|
5
Pfizer
PFE
$160B
| $33M | 0.92% |
1,065,188
+207,501
| +24% | +$7.07M |
|
6
Booking.com
BKNG
$158B
| $31.3M | 0.87% |
582,000
+164,375
| +39% | +$11.5M |
|
|
7
TJX Companies
TJX
$155B
| $31M | 0.86% |
647,890
+604,507
| +1,393% | +$34.8M |
|
|
8
Medtronic
MDT
$119B
| $29.3M | 0.81% |
324,454
+254,530
| +364% | +$27.1M |
|
9
AT&T
T
$173B
| $27.1M | 0.75% |
1,231,978
-640,824
| -34% | -$17.5M |
|
10
Honeywell
HON
$68.4B
| $27.1M | 0.75% |
214,641
-86,280
| -29% | -$13.3M |
|
11
ConocoPhillips
COP
$162B
| $26.4M | 0.73% |
858,539
+387,443
| +82% | +$19.7M |
|
|
RTN
12
DELISTED
Raytheon Company
RTN
| $25.8M | 0.72% |
196,922
+87,212
| +79% | +$17.3M |
|
13
3M
MMM
$92.3B
| $25.6M | 0.71% |
224,187
-27,387
| -11% | -$3.6M |
|
14
Alphabet (Google) Class A
GOOGL
$4.22T
| $25.5M | 0.71% |
439,720
-10,180
| -2% | -$690K |
|
15
RTX Corp
RTX
$283B
| $24.4M | 0.68% |
410,826
-138,332
| -25% | -$11.7M |
|
16
Target
TGT
$75.1B
| $24M | 0.67% |
258,679
-36,866
| -12% | -$4.09M |
|
17
Altria Group
MO
$110B
| $23.6M | 0.66% |
610,157
-49,585
| -8% | -$2.2M |
|
18
Verizon
VZ
$205B
| $23.4M | 0.65% |
435,187
-310,124
| -42% | -$17.7M |
|
19
Merck
MRK
$376B
| $23M | 0.64% |
313,688
-67,448
| -18% | -$5.3M |
|
|
20
Kinder Morgan
KMI
$69B
| $22.6M | 0.63% |
1,624,372
+1,460,945
| +894% | +$27.8M |
|
21
Cisco
CSCO
$438B
| $22.2M | 0.62% |
564,825
-620,562
| -52% | -$27.2M |
|
22
Amazon
AMZN
$2.79T
| $20.7M | 0.58% |
212,780
+5,960
| +3% | +$577K |
|
23
Campbell Soup
CPB
$7.14B
| $20.2M | 0.56% |
438,520
+142,543
| +48% | +$6.86M |
|
24
Procter & Gamble
PG
$336B
| $20M | 0.55% |
181,470
-5,622
| -3% | -$675K |
|
25
General Dynamics
GD
$104B
| $19.8M | 0.55% |
149,267
+129,824
| +668% | +$21.6M |
|
Similar funds
Joel Greenblatt's Q1 2020 Portfolio in Review
As of Q1 2020, Joel Greenblatt held 1,293 positions worth $3.6B, down 34% from $5.45B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Joel Greenblatt withdrew a net $266M in Q1 2020, closing 238 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $28.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in CONCHO RESOURCES INC. worth $16.6M.
- Joel Greenblatt's largest Q1 2020 buy was CONCHO RESOURCES INC.: 388,298 shares worth $16.6M.
- Joel Greenblatt added most to TJX Companies in Q1 2020, an estimated $34.8M increase.
- Joel Greenblatt's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $42.7M.
- Joel Greenblatt fully exited Johnson Controls International in Q1 2020, selling an estimated $28.1M.
- Joel Greenblatt's ten largest holdings make up 9.7% of its $3.6B portfolio in Q1 2020.
- Joel Greenblatt opened 206 new positions and closed 238 in Q1 2020.
- Joel Greenblatt's portfolio value fell 34% quarter-over-quarter to $3.6B.
Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.